References
- Monath TP. Yellow fever: an update. Lancet Infect Dis 2001; 1:11-20; PMID:11871403; http://dx.doi.org/10.1016/S1473-3099(01)00016-0
- Monath TP. Yellow fever vaccine. In: Plotkin SA, Orenstein WA, Offit PA, eds. Vaccines: Saunders, 2008:1748
- Ljungman P, Cordonnier C, Einsele H, Englund J, Machado CM, Storek J, Small T. Vaccination of hematopoietic cell transplant recipients. Bone Marrow Transplantation 2009; 44:521-6; PMID:19861986; http://dx.doi.org/10.1038/bmt.2009.263
- Effros RB, Fletcher CV, Gebo K, Halter JB, Hazzard WR, Horne FM, Huebner RE, Janoff EN, Justice AC, Kuritzkes D, et al. Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions. Clin Infect Dis 2008; 47:542-53; PMID:18627268; http://dx.doi.org/10.1086/590150
- Reinhardt B, Jaspert R, Niedrig M, Kostner C, L'Age-Stehr J. Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection. J Med Virol 1998; 56:159-67; PMID:9746073; http://dx.doi.org/10.1002/(SICI)1096-9071(199810)56:2<159::AID-JMV10>3.0.CO;2-B
- Barrett AD, Teuwen DE. Yellow fever vaccine - how does it work and why do rare cases of serious adverse events take place? Curr Opin Immunol 2009; 21:308-13; PMID:19520559; http://dx.doi.org/10.1016/j.coi.2009.05.018
- Avelino-Silva VI, Leal FE, Sabino EC, Nishiya AS, da Silva Freire M, Blumm F, Rocha V, Rodrigues CA, Novis YS, et al. Yellow fever vaccine viremia following ablative BM suppression in AML. Bone Marrow Transplantation 2013; 48:1008-9; PMID:23334273; http://dx.doi.org/10.1038/bmt.2012.277
- Simoes M, Camacho LA, Yamamura AM, Miranda EH, Cajaraville AC, da Silva Freire M. Evaluation of accuracy and reliability of the plaque reduction neutralization test (micro-PRNT) in detection of yellow fever virus antibodies. Biologicals 2012; 40:399-404; PMID:23034357; http://dx.doi.org/10.1016/j.biologicals.2012.09.005
- Spoulou V, Giannaki M, Vounatsou M, Bakoula C, Grafakos S. Long-term immunity to measles, mumps and rubella after MMR vaccination among children with bone marrow transplants. Bone Marrow Transplant 2004; 33:1187-90; PMID:15077129; http://dx.doi.org/10.1038/sj.bmt.1704476
- Parkkali T, Ruutu T, Stenvik M, Kuronen T, Kayhty H, Hovi T, Olander RM, Volin L, Ruutu P. Loss of protective immunity to polio, diphtheria and Haemophilus influenzae type b after allogeneic bone marrow transplantation. APMIS 1996; 104:383-8; PMID:8703445; http://dx.doi.org/10.1111/j.1699-0463.1996.tb00731.x
- Parkkali T, Olander RM, Ruutu T, Vuontela K, Volin L, Eskola J, Ruutu P. A randomized comparison between early and late vaccination with tetanus toxoid vaccine after allogeneic BMT. Bone Marrow Transplantation 1997; 19:933-8; PMID:9156269; http://dx.doi.org/10.1038/sj.bmt.1700768